Literature DB >> 17283115

Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk.

Kari Hemminki1, Jianguang Ji, Asta Försti.   

Abstract

The reasons for the high risk of contralateral breast cancer are not understood, although polygenic mechanisms have been suggested to be involved. The nationwide Swedish Family-Cancer Database was used to examine the interaction of the risks for contralateral and familial cancer. Relative risks were separately determined for contralateral and familial breast cancers, and these were tested for additive and multiplicative interactions. The Database contained information on 102,176 first breast cancers. Familial risk for breast cancer was 1.76 and the risk for contralateral breast cancer was 3.40, or 5.80 when extrapolated to two breasts. When women had a family history, the risk for contralateral breast cancer was remarkably high, 5.48, or 9.96 when the risk was extrapolated to two breasts, almost identical with 10.21, which was predicted by the multiplicative model. Although the data do not rule out polygenic mechanisms, they suggest that epigenetic imprinting events may be involved for the contralateral breast cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17283115     DOI: 10.1158/0008-5472.CAN-06-3854

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

Review 1.  Second malignant neoplasms and cardiovascular disease following radiotherapy.

Authors:  Lois B Travis; Andrea K Ng; James M Allan; Ching-Hon Pui; Ann R Kennedy; X George Xu; James A Purdy; Kimberly Applegate; Joachim Yahalom; Louis S Constine; Ethel S Gilbert; John D Boice
Journal:  J Natl Cancer Inst       Date:  2012-02-06       Impact factor: 13.506

2.  Cost-effectiveness of contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast cancer.

Authors:  Benjamin Zendejas; James P Moriarty; Jamie O'Byrne; Amy C Degnim; David R Farley; Judy C Boughey
Journal:  J Clin Oncol       Date:  2011-06-20       Impact factor: 44.544

3.  Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.

Authors:  Jonine L Bernstein; Robert W Haile; Marilyn Stovall; John D Boice; Roy E Shore; Bryan Langholz; Duncan C Thomas; Leslie Bernstein; Charles F Lynch; Jorgen H Olsen; Kathleen E Malone; Lene Mellemkjaer; Anne-Lise Borresen-Dale; Barry S Rosenstein; Sharon N Teraoka; Anh T Diep; Susan A Smith; Marinela Capanu; Anne S Reiner; Xiaolin Liang; Richard A Gatti; Patrick Concannon
Journal:  J Natl Cancer Inst       Date:  2010-03-19       Impact factor: 13.506

Review 4.  The association between prognosis of breast cancer and first-degree family history of breast or ovarian cancer: a systematic review and meta-analysis.

Authors:  Jun-Long Song; Chuang Chen; Jing-Ping Yuan; Sheng-Rong Sun
Journal:  Fam Cancer       Date:  2017-07       Impact factor: 2.375

5.  Second primary breast cancer occurrence according to hormone receptor status.

Authors:  Allison W Kurian; Laura A McClure; Esther M John; Pamela L Horn-Ross; James M Ford; Christina A Clarke
Journal:  J Natl Cancer Inst       Date:  2009-07-09       Impact factor: 13.506

6.  Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.

Authors:  J O Culver; C D Brinkerhoff; J Clague; K Yang; K E Singh; S R Sand; J N Weitzel
Journal:  Clin Genet       Date:  2013-02-20       Impact factor: 4.438

7.  Incident malignancies among older long-term breast cancer survivors and an age-matched and site-matched nonbreast cancer comparison group over 10 years of follow-up.

Authors:  Kerri M Clough-Gorr; Soe Soe Thwin; Jaclyn L F Bosco; Rebecca A Silliman; Diana S M Buist; Pamala A Pawloski; Virginia P Quinn; Marianne N Prout
Journal:  Cancer       Date:  2012-12-26       Impact factor: 6.860

8.  Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.

Authors:  Anne S Reiner; Esther M John; Jennifer D Brooks; Charles F Lynch; Leslie Bernstein; Lene Mellemkjær; Kathleen E Malone; Julia A Knight; Marinela Capanu; Sharon N Teraoka; Patrick Concannon; Xiaolin Liang; Jane C Figueiredo; Susan A Smith; Marilyn Stovall; Malcolm C Pike; Robert W Haile; Duncan C Thomas; Colin B Begg; Jonine L Bernstein
Journal:  J Clin Oncol       Date:  2012-12-26       Impact factor: 44.544

9.  Should breast cancer survivors be excluded from, or invited to, organised mammography screening programmes?

Authors:  Lauro Bucchi
Journal:  BMC Health Serv Res       Date:  2011-10-04       Impact factor: 2.655

Review 10.  Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.

Authors:  Mark J Messina; Charles E Wood
Journal:  Nutr J       Date:  2008-06-03       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.